Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ContextLogic Inc. - Class A Common Stock (NQ: LOGC )

5.500 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 5.500
Bid (Size) 5.400 (1)
Ask (Size) 5.750 (1)
Prev. Close 5.500
Today's Range 5.500 - 5.500
52wk Range 4.920 - 6.290
Shares Outstanding 32,962,733
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LOGC Stock Earnings: ContextLogic Misses EPS, Beats Revenue for Q2 2024
LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
ContextLogic Inc. Reports Second-Quarter Financial Results
From ContextLogic Inc.
Via GlobeNewswire

Performance

YTD
-1.26%
-1.26%
1 Month
-4.84%
-4.84%
3 Month
+2.04%
+2.04%
6 Month
-1.26%
-1.26%
1 Year
-1.26%
-1.26%

More News

Read More
11 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC),
From Brodsky & Smith LLC
Via GlobeNewswire
Looking Into LogicBio Therapeutics's Recent Short Interest
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), Coffee Holding Co., Inc. (Nasdaq – JVA)
From Brodsky & Smith LLC
Via GlobeNewswire
LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) CarLotz, Inc. (Nasdaq – LOTZ), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA)
From Brodsky & Smith LLC
Via GlobeNewswire
LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC
From Kahn Swick & Foti, LLC
Via Business Wire
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Jumps 270 Points; Silver Surges Over 8%
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA), BTRS Holdings Inc. (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
S&P 500 Surges 2%; Crude Oil Rises Sharply
Via Benzinga
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
Via InvestorPlace
Blue Apron (APRN) Stock Falls 33% on CFO Departure, Stock Sale
Via InvestorPlace
Why Is LogicBio (LOGC) Stock Up 600% Today?
Via InvestorPlace
LOGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LogicBio Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why LogicBio Therapeutics Stock Is Soaring Today
Via Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
Via Benzinga
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine
From Alexion
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.